Genetics of Latent Autoimmune Diabetes in Adults

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

205 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-07-31

Study Completion Date

2017-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a prospective study that will study adults and has the objective of examining 'Latent Autoimmune Diabetes in Adults' (LADA) to understand how this trait is influenced by genetic factors.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Neurologic and Immunologic Characteristics of CTLA-4 and LRBA Hereditary Deficiency

NCT05040256

CTLA4 Haploinsufficiency

COMPLETED

The LD Lync Study - Natural History Study of Lipodystrophy Syndromes

NCT03087253

Lipodystrophy (Genetic or Acquired, Non HIV)

RECRUITING

Genetic Studies of X-linked Lymphoproliferative Disease

NCT00359411

X-Linked Lymphoproliferative Disease Lymphoproliferative Disease Genetic Diseases, X-Linked

COMPLETED

Identification and Characterization of Monogenic Diabetes

NCT01481623

Diabetes

UNKNOWN NA

Observational Study of Advanced Data Analytics in Genetic Conditions

NCT05657405

Genetic Conditions

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A case-control study approach will be used to compare the allelic frequencies of Deoxyribonucleic acid (DNA) markers of the cases (i.e., LADA patients) to a randomly selected control samples that does not have the trait under study. To study the role of genetic factors in LADA, the study seeks to determine if certain genomic regions that are captured or mirrored by selective Single nucleotide polymorphisms (SNPs) that are genotyped, are over or underrepresented in those with the disease compared to those who do not. The level of auto-antibodies is the serum can also be studied as a quantitative trait where we ask the question if there is correlation with specific SNP alleles that are genotyped. The markers that are found to be over or under-represented in the study cases will then be tested in an independent set of patients also recruited in this study. This allows us to filter markers that show significance simply by chance and prevents us from being misled.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Latent Autoimmune Diabetes in Adult

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Latent Autoimmune Diabetes in Adult

Individuals who meet criteria for Latent Autoimmune Diabetes in Adult

No interventions assigned to this group

Without Latent Autoimmune Diabetes in Adult

Individuals who do not meet criteria for Latent Autoimmune Diabetes in Adult

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed type 2 Diabetes (T2D) patient with: BMI \<30 at diagnosis; Age \>25-\<50 at diagnosis

OR

* Diagnosed type 1 Diabetes (T1D) patient with: Age \>25 at diagnosis

OR

\- Currently Diagnosed with LADA with age at initial diagnosis of Diabetes \>25 years and a positive GAD65 antibody test

Exclusion Criteria

* Any underlying disease or condition that is a contraindication for obtaining 18.0 ml of blood.
* Inability to obtain an informed consent from a given LADA case.
* Blood sampling has already occurred for a given subject.
* Previous GAD65 antibody test(s) negative.

Minimum Eligible Age

25 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No